The Brink's Company Earnings Call Transcripts
Fiscal Year 2026
-
Q2 saw 7% revenue growth and record margins, with AMS/DRS up 14% and strong free cash flow. The NCR Atleos acquisition advanced with major regulatory clearances and 99% shareholder approval. Full-year guidance was raised, with continued margin expansion and robust growth expected in AMS/DRS.
-
A special meeting was held to approve a share issuance related to a merger with NCR Atleos Corporation. With a quorum of 91.63% present, the proposal passed and final results will be filed with the SEC.
-
Q1 delivered strong revenue and EBITDA growth, with AMS and DRS driving recurring high-margin gains. The NCR Atleos acquisition is progressing, with integration planning underway and leverage reduction prioritized. Guidance for 2026 and Q2 remains robust.
-
A $6.6B acquisition will merge two top fintech providers, forming a $10B revenue company with strong recurring revenue, $200M in annual cost synergies, and growth in ATM managed services and digital retail solutions. The deal, closing in Q1 2027, is highly accretive to EPS and will deliver $1B in annual free cash flow.
Fiscal Year 2025
-
A $6.6B acquisition will create a $10B revenue, $2B EBITDA company with strong recurring revenue, $200M in cost synergies, and over $1B in free cash flow expected. The deal is highly accretive, with robust growth in AMS/DRS and a focus on rapid deleveraging.
-
Q3 saw 6% revenue growth and record margins, driven by AMS/DRS expansion and productivity gains. AMS/DRS now accounts for 28% of revenue, with organic growth accelerating to 19%. Full-year guidance is affirmed, with strong free cash flow and continued capital returns to shareholders.
-
Strong Q2 results featured 5% organic revenue growth, record margins, and robust free cash flow. AMSDRS and Global Services segments are accelerating, prompting increased full-year guidance for revenue and EBITDA. Over 50% of free cash flow will be returned to shareholders.
-
Q1 2025 saw 6% organic growth, record operating profits, and strong AMS DRS momentum, with recurring revenue now a quarter of the business. Guidance for 2025 is reaffirmed, with margin expansion and robust capital returns expected, despite FX and interest income headwinds.
Fiscal Year 2024
-
Organic growth reached 12% for the year, with AMS DRS up 23% and now 24% of revenue. EBITDA hit $912M and margins expanded, despite FX headwinds. 2025 guidance calls for mid-single-digit organic growth, margin expansion, and continued strong free cash flow conversion.
-
Q3 saw 13% organic growth, led by AMS and DRS at 26%, but FX headwinds and a $10M security loss impacted margins and cash flow. 2024 guidance was revised for lower EBITDA and free cash flow, yet AMS/DRS growth outlook remains strong, with major customer wins and continued share repurchases.
-
Organic revenue grew 14% with AMS/DRS up 26% and CVM up 10%, driving 16% EBITDA growth and 31% EPS growth. Margin expansion and productivity gains offset FX headwinds, and full-year guidance for double-digit EBITDA and strong free cash flow is reaffirmed.